BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace


Strateos logo

United States of America based
$100.370 M

Strateos automates chemistry, biology, and tissue analysis into closed loop robotic labs that accelerate drug discovery programs. Through a combination of best-in-class robotics and control systems, advanced software for imaging and analytics, and remote cloud laboratories, we enable our pharmaceutical partners to more rapidly and efficiently discover new drug candidates.

Born of a merger between Transcriptic and 3Scan, Strateos combines the strengths of those companies to amplify their impact and accelerate drug discovery.

Transcriptic developed the first robotic cloud laboratory platform for on-demand life science research, which is currently in use at several top pharmaceutical and biotechnology companies. 3Scan combines automation, machine learning and computer vision to extract spatial data from tissue samples and create detailed 3D representations as well as quantitative analysis of complex anatomical structures. Now these two portfolios will be combined to offer a suite of technologies for accelerating drug discovery and early development.


AI Companies (Drug Discovery)   Medical Robotics Startups  

Posts Mentioning This Company

R&D Platform

Powered by SCLE, the Strateos Robotic Cloud Platform transforms life science research by providing more efficient, reproducible research on demand from anywhere in the world through a single user interface.


No pipelines published yet




No services posted yet